Termeer created a business model created by many others in the biotech industry by creating steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. He was born in Tilburg, Netherlands.